Risk Assessment in a Global CVD Prevention Cohort of People With HIV by PCE, PREVENT, and SCORE2
Steven Grinspoon(Massachusetts General Hospital), Markella V. Zanni(Harvard University), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Virginia A. Triant(Brigham and Women's Hospital), Pamela S. Douglas(Duke University), Sophia Zhao(Harvard University), Michael T. Lu(Cancer Research And Biostatistics), Triin Umbleja(Harvard University), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Estebán Martínez(Instituto de Salud Carlos III), Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Sara McCallum(Cancer Research And Biostatistics), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Kristine M. Erlandson(University of Colorado Denver)
Cited by 5
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k